We are live on ! Find out more
CODX icon

Co-Diagnostics
CODX

7 hedge funds and large institutions have $327K invested in Co-Diagnostics in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

40% more funds holding

Funds holding: 5 → 7 (+2)

0.19% less ownership

Funds ownership: 1.93% → 1.74% (-0.19%)

31% less capital inflows, than outflows

Capital inflows: $68.5K | Capital outflows: $98.5K

Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HighTower Advisors
HighTower Advisors
Illinois
+$35.8K
2
Citadel Advisors
Citadel Advisors
Florida
+$20.8K
3
Advisor Group
Advisor Group
Arizona
+$6.53K
4
UBS Group
UBS Group
Switzerland
+$3.27K
5
Deutsche Bank
Deutsche Bank
Germany
+$2.09K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$98.5K

CODX Hedge Fund Activity: Q4 2018 in Review

7 of the 4,506 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q4 2018, worth a combined $327K — down 48% from $625K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CODX positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was HighTower Advisors, adding an estimated $35.8K. The largest seller was Vanguard Group, cutting an estimated $98.5K.

  • 7 institutional investors held Co-Diagnostics (CODX) as of Q4 2018, up from 5 in Q3 2018.
  • Funds reported $327K of Co-Diagnostics stock for Q4 2018, down 48% quarter-over-quarter.
  • 2 funds opened new Co-Diagnostics positions in Q4 2018 and 0 closed out, a net change of +2 holders.
  • The largest Co-Diagnostics buyer in Q4 2018 was HighTower Advisors, an estimated $35.8K added.
  • The largest Co-Diagnostics seller in Q4 2018 was Vanguard Group, an estimated $98.5K sold.

Based on aggregated 13F filings for Q4 2018.